Literature DB >> 18070909

Toll-like receptors and leishmaniasis.

Felipe F Tuon1, Valdir S Amato, Hélio A Bacha, Tariq Almusawi, Maria I Duarte, Vicente Amato Neto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070909      PMCID: PMC2258802          DOI: 10.1128/IAI.01090-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  93 in total

Review 1.  Leishmanial infection: analysis of its first steps. A review.

Authors:  M C de Almeida; V Vilhena; A Barral; M Barral-Netto
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-01-07       Impact factor: 2.743

Review 2.  Leucine-rich repeats in host-pathogen interactions.

Authors:  Łukasz Kedzierski; Jacqui Montgomery; Joan Curtis; Emanuela Handman
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2004 Mar-Apr       Impact factor: 4.291

Review 3.  Mutational and functional analysis of the Leishmania surface metalloproteinase GP63: similarities to matrix metalloproteinases.

Authors:  W R McMaster; C J Morrison; M H MacDonald; P B Joshi
Journal:  Parasitology       Date:  1994       Impact factor: 3.234

4.  Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.

Authors:  Tsugumi Okusawa; Mari Fujita; Jun-Ichiro Nakamura; Takeshi Into; Motoaki Yasuda; Atsutoshi Yoshimura; Yoshitaka Hara; Akira Hasebe; Douglas T Golenbock; Manabu Morita; Yoshio Kuroki; Tomohiko Ogawa; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice.

Authors:  Uta G Lange; Pietro Mastroeni; Jenefer M Blackwell; Carmel B Stober
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 6.  Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.

Authors:  Jory R Baldridge; Patrick McGowan; Jay T Evans; Christopher Cluff; Sally Mossman; David Johnson; David Persing
Journal:  Expert Opin Biol Ther       Date:  2004-07       Impact factor: 4.388

7.  Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.

Authors:  M J McConville; L F Schnur; C Jaffe; P Schneider
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

8.  Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major.

Authors:  Pascale Kropf; Marina A Freudenberg; Manuel Modolell; Helen P Price; Shanti Herath; Simone Antoniazi; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.

Authors:  P Kropf; N Freudenberg; C Kalis; M Modolell; S Herath; C Galanos; M Freudenberg; I Müller
Journal:  J Leukoc Biol       Date:  2004-03-23       Impact factor: 4.962

10.  IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?

Authors:  Y Li; K Ishii; H Hisaeda; S Hamano; M Zhang; K Nakanishi; T Yoshimoto; H Hemmi; K Takeda; S Akira; Y Iwakura; K Himeno
Journal:  Gene Ther       Date:  2004-06       Impact factor: 5.250

View more
  52 in total

1.  Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis.

Authors:  Carolina Gallego; Douglas Golenbock; Maria Adelaida Gomez; Nancy Gore Saravia
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection.

Authors:  Tiffany Weinkopff; Anita Mariotto; Gregoire Simon; Yazmin Hauyon-La Torre; Floriane Auderset; Steffen Schuster; Haroun Zangger; Nicolas Fasel; Aldina Barral; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

3.  Immunoregulatory profile of monocytes from cutaneous leishmaniasis patients and association with lesion size.

Authors:  É L M Vieira; T S L Keesen; P R Machado; L H Guimarães; E M Carvalho; W O Dutra; K J Gollob
Journal:  Parasite Immunol       Date:  2013-02       Impact factor: 2.280

4.  Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.

Authors:  H S Chandel; S P Pandey; D Shukla; K Lalsare; S K Selvaraj; M K Jha; B Saha
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

5.  Signaling networks in Leishmania macrophages deciphered through integrated systems biology: a mathematical modeling approach.

Authors:  Milsee Mol; Milind S Patole; Shailza Singh
Journal:  Syst Synth Biol       Date:  2013-07-04

6.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.

Authors:  Henry W Murray; Yunhua Zhang; Yan Zhang; Vanitha S Raman; Steven G Reed; Xiaojing Ma
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

7.  Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice.

Authors:  Mousa Komai-Koma; Dong Li; Eryi Wang; Diane Vaughan; Damo Xu
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

8.  Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia.

Authors:  Joel Désiré Kamda; Steven M Singer
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

Review 9.  The global cysteine peptidase landscape in parasites.

Authors:  Holly J Atkinson; Patricia C Babbitt; Mohammed Sajid
Journal:  Trends Parasitol       Date:  2009-10-24

10.  Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps.

Authors:  Anderson B Guimarães-Costa; Michelle T C Nascimento; Giselle S Froment; Rodrigo P P Soares; Fernanda N Morgado; Fátima Conceição-Silva; Elvira M Saraiva
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.